Latest Jeito bet positions European VC for fourth exit

Jeito’s latest investment, co-leading Alentis’ $181 million series D round, shows the firm executing on its mission statement four years after debuting its inaugural €534 million fund and having notched a trio of exits.

It’s also the third time Jeito Capital has invested in Alentis Therapeutics AG, as the firm follows its playbook: continuing to lead or co-lead rounds, guiding a company through its earliest phases with an eye toward going to market. ...